Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 128

1.

Thresholds for Initiating Treatment of Eyes with Diabetic Macular Edema and Good Vision: Consideration of DRCR.Net Protocol V Results.

Wykoff CC.

Ophthalmol Retina. 2019 Nov;3(11):917-919. doi: 10.1016/j.oret.2019.07.007. Epub 2019 Jul 20. No abstract available.

PMID:
31699307
2.

Protecting Vision in Patients With Diabetes With Ultra-Widefield Imaging: A Review of Current Literature.

Singh RP, Hsueh J, Han MM, Kuriyan AE, Conti FF, Steinle N, Weng CY, Wong RW, Martinez JA, Wykoff CC.

Ophthalmic Surg Lasers Imaging Retina. 2019 Oct 1;50(10):639-648. doi: 10.3928/23258160-20191009-07.

PMID:
31671197
3.

Noncompliance in Prospective Retina Clinical Trials: Analysis of factors predicting loss to follow up.

Zhou B, Mitchell TC, Rusakevich AM, Brown DM, Wykoff CC.

Am J Ophthalmol. 2019 Oct 21. pii: S0002-9394(19)30505-7. doi: 10.1016/j.ajo.2019.10.012. [Epub ahead of print]

PMID:
31647931
4.

Quarterly Anti-Vascular Endothelial Growth Factor Dosing for Neovascular Age-Related Macular Degeneration: Real-World Clinical Outcomes.

Rusakevich AM, Zhou B, Wong TP, Wykoff CC.

Ophthalmic Surg Lasers Imaging Retina. 2019 Sep 1;50(9):e250-e256. doi: 10.3928/23258160-20190905-17.

PMID:
31589766
5.

Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial.

Wykoff CC, Nittala MG, Zhou B, Fan W, Velaga SB, Lampen SIR, Rusakevich AM, Ehlers JP, Babiuch A, Brown DM, Ip MS, Sadda SR; RECOVERY Study Group.

Ophthalmol Retina. 2019 Jul 24. pii: S2468-6530(19)30470-1. doi: 10.1016/j.oret.2019.07.011. [Epub ahead of print]

PMID:
31542339
6.

Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.

Liao DS, Grossi FV, El Mehdi D, Gerber MR, Brown DM, Heier JS, Wykoff CC, Singerman LJ, Abraham P, Grassmann F, Nuernberg P, Weber BHF, Deschatelets P, Kim RY, Chung CY, Ribeiro RM, Hamdani M, Rosenfeld PJ, Boyer DS, Slakter JS, Francois CG.

Ophthalmology. 2019 Jul 16. pii: S0161-6420(18)33132-4. doi: 10.1016/j.ophtha.2019.07.011. [Epub ahead of print]

7.

Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography.

Fan W, Nittala MG, Fleming A, Robertson G, Uji A, Wykoff CC, Brown DM, van Hemert J, Ip M, Wang K, Falavarjani KG, Singer M, Sagong M, Sadda SR.

Am J Ophthalmol. 2019 Aug 29. pii: S0002-9394(19)30416-7. doi: 10.1016/j.ajo.2019.08.015. [Epub ahead of print]

PMID:
31472160
8.

SEVERITY OF DIABETIC MACULAR EDEMA CORRELATES WITH RETINAL VASCULAR BED AREA ON ULTRA-WIDE FIELD FLUORESCEIN ANGIOGRAPHY: DAVE Study.

Fan W, Uji A, Wang K, Falavarjani KG, Wykoff CC, Brown DM, Van Hemert J, Sagong M, Sadda SR, Ip M.

Retina. 2019 Jul 26. doi: 10.1097/IAE.0000000000002579. [Epub ahead of print]

PMID:
31356494
9.

Office-based intravitreal injection of expansile gas for management of macular hole in previously vitrectomized eyes.

Apolinario MA, Lampen SIR, Wong TP, Henry CR, Wykoff CC.

Am J Ophthalmol Case Rep. 2019 Jul 5;15:100492. doi: 10.1016/j.ajoc.2019.100492. eCollection 2019 Sep.

10.

Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data.

Sadda SR, Campbell J, Dugel PU, Holekamp NM, Kiss S, Loewenstein A, Augustin AJ, Shih V, Xu X, Wykoff CC, Whitcup SM.

Eye (Lond). 2019 Jul 18. doi: 10.1038/s41433-019-0522-z. [Epub ahead of print]

PMID:
31320738
11.

Looking ahead in retinal disease management: highlights of the 2019 angiogenesis, exudation and degeneration symposium.

Puliafito CA, Wykoff CC.

Int J Retina Vitreous. 2019 May 29;5:22. doi: 10.1186/s40942-019-0174-y. eCollection 2019. No abstract available.

12.

Real-World Trends in Intravitreal Injection Practices among American Retina Specialists.

Chaturvedi R, Wannamaker KW, Riviere PJ, Khanani AM, Wykoff CC, Chao DL.

Ophthalmol Retina. 2019 Aug;3(8):656-662. doi: 10.1016/j.oret.2019.03.023. Epub 2019 Apr 4.

PMID:
31133544
13.

Intravitreal Fluocinolone Acetonide May Decelerate Diabetic Retinal Neurodegeneration.

Lynch SK, Lee K, Chen Z, Folk JC, Schmidt-Erfurth U, Gerendas BS, Wahle A, Wykoff CC, Abràmoff MD.

Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2134-2139. doi: 10.1167/iovs.18-24643.

14.

Distribution of Non-perfusion and Neovascularization on Ultra-Wide Field Fluorescein Angiography in Proliferative Diabetic Retinopathy (RECOVERY Study): Report 1.

Fan W, Nittala MG, Velaga SB, Hirano T, Wykoff CC, Ip M, Lampen SIR, van Hemert J, Fleming A, Verhoek M, Sadda SR.

Am J Ophthalmol. 2019 May 9. pii: S0002-9394(19)30204-1. doi: 10.1016/j.ajo.2019.04.023. [Epub ahead of print]

PMID:
31078541
15.

Suprachoroidal Triamcinolone Acetonide for Diabetic Macular Edema: The HULK Trial.

Wykoff CC, Khurana RN, Lampen SIR, Noronha G, Brown DM, Ou WC, Sadda SR; HULK Study Group.

Ophthalmol Retina. 2018 Aug;2(8):874-877. doi: 10.1016/j.oret.2018.03.008. Epub 2018 May 4. No abstract available.

PMID:
31047542
16.

Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy.

Wykoff CC, Eichenbaum DA, Roth DB, Hill L, Fung AE, Haskova Z.

Ophthalmol Retina. 2018 Oct;2(10):997-1009. doi: 10.1016/j.oret.2018.06.005. Epub 2018 Aug 1.

PMID:
31047503
17.

Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study.

Campochiaro PA, Wykoff CC, Brown DM, Boyer DS, Barakat M, Taraborelli D, Noronha G; Tanzanite Study Group.

Ophthalmol Retina. 2018 Apr;2(4):320-328. doi: 10.1016/j.oret.2017.07.013. Epub 2017 Sep 29.

PMID:
31047241
18.

Classification of Regions of Nonperfusion on Ultra-widefield Fluorescein Angiography in patients with Diabetic Macular Edema.

Fang M, Fan W, Shi Y, Ip MS, Wykoff CC, Wang K, Falavarjani KG, Brown DM, van Hemert J, Sadda SR.

Am J Ophthalmol. 2019 Apr 5. pii: S0002-9394(19)30141-2. doi: 10.1016/j.ajo.2019.03.030. [Epub ahead of print]

PMID:
30959003
19.

Longitudinal Retinal Perfusion Status in Eyes with Diabetic Macular Edema Receiving Intravitreal Aflibercept or Laser in VISTA Study.

Wykoff CC, Shah C, Dhoot D, Coleman HR, Thompson D, Du W, Baker K, Vitti R, Berliner AJ, Metzig C, Saroj N.

Ophthalmology. 2019 Aug;126(8):1171-1180. doi: 10.1016/j.ophtha.2019.03.040. Epub 2019 Apr 1.

PMID:
30946887
20.

Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial.

Sahni J, Patel SS, Dugel PU, Khanani AM, Jhaveri CD, Wykoff CC, Hershberger VS, Pauly-Evers M, Sadikhov S, Szczesny P, Schwab D, Nogoceke E, Osborne A, Weikert R, Fauser S.

Ophthalmology. 2019 Aug;126(8):1155-1170. doi: 10.1016/j.ophtha.2019.03.023. Epub 2019 Mar 21.

Supplemental Content

Loading ...
Support Center